Accéder au contenu
Merck

The gastrointestinal pathogen Campylobacter jejuni metabolizes sugars with potential help from commensal Bacteroides vulgatus.

Communications biology (2020-01-12)
Jolene M Garber, Harald Nothaft, Ben Pluvinage, Martin Stahl, Xiaoming Bian, Sara Porfirio, Amber Enriquez, James Butcher, Hua Huang, John Glushka, Eric Line, John A Gerlt, Parastoo Azadi, Alain Stintzi, Alisdair B Boraston, Christine M Szymanski
RÉSUMÉ

Although the gastrointestinal pathogen Campylobacter jejuni was considered asaccharolytic, >50% of sequenced isolates possess an operon for L-fucose utilization. In C. jejuni NCTC11168, this pathway confers L-fucose chemotaxis and competitive colonization advantages in the piglet diarrhea model, but the catabolic steps remain unknown. Here we solved the putative dehydrogenase structure, resembling FabG of Burkholderia multivorans. The C. jejuni enzyme, FucX, reduces L-fucose and D-arabinose in vitro and both sugars are catabolized by fuc-operon encoded enzymes. This enzyme alone confers chemotaxis to both sugars in a non-carbohydrate-utilizing C. jejuni strain. Although C. jejuni lacks fucosidases, the organism exhibits enhanced growth in vitro when co-cultured with Bacteroides vulgatus, suggesting scavenging may occur. Yet, when excess amino acids are available, C. jejuni prefers them to carbohydrates, indicating a metabolic hierarchy exists. Overall this study increases understanding of nutrient metabolism by this pathogen, and identifies interactions with other gut microbes.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-(−)-Galactose, ≥99% (HPLC)